Alabama vs New Jersey on USAspending: $7.7B vs $8.1B

Matched billions, a 7-to-1 award file

These figures are USAspending.gov obligations, not Treasury outlays. New Jersey’s $8.1B edges Alabama’s $7.7B. Place of performance in the award file is the scoring rule. Among two states with stocks that round to the same billion, the paperwork volume is the split that matters: 1,162,765 actions in New Jersey versus 161,254 in Alabama.

That row gap implies a much smaller typical booking in New Jersey. Alabama’s $7,682,295,934 sits on 161,254 records. New Jersey’s $8,084,032,234 is spread across more than a million actions. Dollars are close; row counts are not. The $8.1B versus $7.7B ranking is a dollar ranking, not a row ranking.

A 7-to-1 award gap on stocks of $7,682,295,934 and $8,084,032,234 means New Jersey’s 1,162,765 actions are the high-volume file and Alabama’s 161,254 actions are the heavier typical booking. Census counts of 5,157,699 versus 9,500,851 explain $116.81 versus $92.49. FY2026 of $602,489,799 versus $878,702,039 should not be folded into those stacked totals. Construction versus pharmaceuticals is mix.

Fewer people in Alabama, higher intensity

New Jersey’s 9,500,851 residents exceed Alabama’s 5,157,699. After dividing the obligation stocks by those Census counts, Alabama shows $116.81 per capita and New Jersey shows $92.49. Intensity favors Alabama even though New Jersey holds the larger stacked total and the much larger award file.

A $116.81 per-person reading in Alabama on 5,157,699 residents is attached to $7.7B. New Jersey’s $92.49 on 9,500,851 residents is attached to $8.1B. This table does not score GDP. It scores USAspending place of performance. Close stocks can hide a wide row-count gap and a quieter intensity gap in the opposite direction.

Construction in Alabama, drug manufacturing in New Jersey

Alabama’s top industry is commercial and institutional building construction. New Jersey’s is pharmaceutical preparation manufacturing. Those labels mark the largest NAICS slice in each state’s file. Building awards and drug-manufacturing awards are different lead products sitting on stocks only $402 million apart.

A construction lead can concentrate facility work inside Alabama’s 161,254-award file. A pharmaceutical-preparation lead inside New Jersey’s 1,162,765-award file can sit among many smaller actions. Mix and scale both differ. Neither industry name explains every dollar in the $7.7B or $8.1B stocks.

FY2026: $602.5M in Alabama vs $878.7M in New Jersey

FY2026 obligations are $602,489,799 in Alabama and $878,702,039 in New Jersey. New Jersey’s latest year is further ahead than the stacked ranking, which is only a $402 million gap. Recency questions belong in FY2026. The stacked totals remain the full USAspending.gov aggregate this comparison uses. Both years are obligations, not outlays.

Do not divide those FY figures by Alabama’s 161,254 or New Jersey’s 1,162,765 all-years awards. Per capita of $116.81 on 5,157,699 residents versus $92.49 on 9,500,851 residents is the intensity comparison. FY2026 answers how the latest year booked. Stacked totals answer how large each file is across the aggregate.

What this pair does and does not show

New Jersey leads stacked dollars ($8.1B vs $7.7B), award count (1,162,765 vs 161,254), population (9,500,851 vs 5,157,699), and FY2026 ($878.7M vs $602.5M). Alabama leads per capita ($116.81 vs $92.49). The distinctive fact is the 7-to-1 row inversion on near-matched billions.

Commercial and institutional building construction versus pharmaceutical preparation manufacturing is mix inside files that contain many other industries. Use the Alabama and New Jersey hubs for agencies and recipients. Keep both $7.7B and $8.1B figures labeled as obligations.

Reading a 7-to-1 row gap on near-matched billions

New Jersey’s 1,162,765 awards on $8,084,032,234 and Alabama’s 161,254 awards on $7,682,295,934 are the same comparison viewed as paperwork instead of dollars. A searcher who only asks which state is larger will miss that New Jersey’s file is a high-volume book and Alabama’s is a heavier typical booking. Populations of 9,500,851 and 5,157,699 explain why per capita still favors Alabama at $116.81 versus $92.49.

FY2026 of $878,702,039 in New Jersey versus $602,489,799 in Alabama is a recency cut, not a substitute for the stacked stocks. Pharmaceutical preparation manufacturing and commercial and institutional building construction are lead industries, not full censuses. Obligations are not Treasury outlays. Place of performance is the scoring rule for both hubs.

Questions

Which state has more federal spending, Alabama or New Jersey?

New Jersey leads in stacked USAspending.gov obligations: $8,084,032,234 versus Alabama’s $7,682,295,934. New Jersey has far more awards (1,162,765 vs 161,254) and more people (9,500,851 vs 5,157,699). Spending per capita is $116.81 in Alabama and $92.49 in New Jersey. FY2026 obligations are $602.5M and $878.7M. These are obligations, not Treasury outlays.

Why does New Jersey have so many more awards than Alabama?

New Jersey logs 1,162,765 awards on $8.1B. Alabama logs 161,254 awards on $7.7B. New Jersey’s file is busier in rows on a near-matched stock, which implies a smaller typical booking. Per capita is $92.49 versus $116.81. Populations are 9,500,851 and 5,157,699. FY2026 favors New Jersey ($878.7M vs $602.5M).

What industries lead Alabama and New Jersey federal awards?

Alabama’s top industry is commercial and institutional building construction. New Jersey’s is pharmaceutical preparation manufacturing. Those slices sit on $7.7B and $8.1B obligation stocks. They mark the largest grouping in each file, not every award in either state. Award counts are 161,254 in Alabama and 1,162,765 in New Jersey.

Are Alabama vs New Jersey figures Treasury outlays?

No. SpendingVault uses USAspending.gov obligations. Outlays are cash payments and can lag. The $7.7B and $8.1B stacked totals and FY2026 amounts of $602.5M and $878.7M measure award commitments by place of performance, not Monthly Treasury Statement payments.